Gilead Sciences, Inc. (GILD) Leads The HCV Race Despite Competition From

Gilead Sciences, Inc. (GILD) Leads The HCV Race Despite Competition From … AbbVie launched its hepatitis C drug, Viekira Pak, with the intent to cannibalize Gilead's hepatitis C drug sales, as evident from the fact that the company immediately went … Continue reading